BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prosolia Benefits From Work of 2002 Nobel Prize Winner


3/6/2012 9:45:17 AM

INDIANAPOLIS, March 6, 2012 /PRNewswire/ -- Today Prosolia and the Estate of the late Prof. John B. Fenn announced an exclusive license agreement providing Prosolia with new sample introduction and ionization technology using a porous "wick" for mass spectrometry and ion mobility systems. The 2002 Nobel Prize winner, Prof. Fenn, developed this new technology. Prof Fenn revolutionized mass spectrometry in the mid-1980s with electrospray ionization (ESI), which catalyzed explosive growth in the mass spectrometry market over the last two decades.

"Prosolia's growing patent portfolio is strong and is a critical element to our business strategy," said Justin Wiseman, President and CEO of Prosolia. "Our agreement with the Fenn Estate strengthens our core and will enable us to continue to provide novel solutions to our customers in both the research and applied markets. The Fenn technology greatly simplifies analytical workflows for sample introduction into mass spectrometers and ion mobility systems, and opens up less penetrated markets in environmental, security, medical, and food chemistry. We foresee several new product innovations from the Fenn technology, which we plan to commercialize in the near future."

Prosolia is a scientific instrument company developing and marketing novel research tools for research scientists and technicians at academic, government, pharmaceutical, clinical, and forensics research laboratories. The company's flagship product is based on the Desorption Electrospray Ionization (DESI) technology. DESI enables rapid spot sampling and imaging of surfaces under ambient conditions using mass spectrometry. Prosolia's current products retrofit onto instruments produced by the major instrument companies, including AB Sciex, Agilent, Bruker, LECO Corp, Thermo Scientific, and Waters.

SOURCE Prosolia, Inc.



Read at BioSpace.com

Prosolia
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES